Specifically, multiple studies in early stage AF patients (lone/paroxysmal AF) report elevated levels of vascular endothelial growth factor A (VEGF; 89–560 pg/ml)3–6,8 and VEGF receptor 2, its primary receptor in the vascular endothelium7. This evidence concerns the gene VEGFA and Paroxysmal atrial fibrillation.